jpm-20220719
false000001961700000196172022-07-192022-07-190000019617us-gaap:CommonStockMember2022-07-192022-07-190000019617jpm:DepositarySharesOneFourHundredthInterestinaShareof5.75NonCumulativePreferredStockSeriesDDMember2022-07-192022-07-190000019617jpm:DepositarySharesOneFourHundredthInterestinaShareof6.00NonCumulativePreferredStockSeriesEEMember2022-07-192022-07-190000019617jpm:DepositarySharesOneFourHundredthInterestinaShareof4.75NonCumulativePreferredStockSeriesGGMember2022-07-192022-07-190000019617jpm:DepositarySharesEachRepresentingAOneFourHundredthInterestInAShareOf455NonCumulativePreferredStockSeriesJJMember2022-07-192022-07-190000019617jpm:DepositarySharesEachRepresentingAOneFourHundredthInterestInAShareOf4625NonCumulativePreferredStockSeriesLLMember2022-07-192022-07-190000019617jpm:DepositarySharesEachRepresentingAOneFourHundredthInterestInAShareOf420NonCumulativePreferredStockSeriesMMMember2022-07-192022-07-190000019617jpm:AlerianMLPIndexETNsDueMay242024Member2022-07-192022-07-190000019617jpm:GuaranteeOfCallableStepUpFixedRateNotesDueJune102032OfJPMorganChaseFinancialCompanyLLCMember2022-07-192022-07-19

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): July 19, 2022
JPMorgan Chase & Co.
(Exact name of registrant as specified in its charter)
Delaware1-580513-2624428
(State or other jurisdiction of
incorporation or organization)		(Commission File Number)(I.R.S. employer
identification no.)
383 Madison Avenue,
New York,New York10179
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (212) 270-6000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common stockJPMThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 5.75% Non-Cumulative Preferred Stock, Series DD
JPM PR DThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 6.00% Non-Cumulative Preferred Stock, Series EE
JPM PR CThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.75% Non-Cumulative Preferred Stock, Series GG
JPM PR JThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.55% Non-Cumulative Preferred Stock, Series JJJPM PR KThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.625% Non-Cumulative Preferred Stock, Series LLJPM PR LThe New York Stock Exchange
Depositary Shares, each representing a one-four hundredth interest in a share of 4.20% Non-Cumulative Preferred Stock, Series MMJPM PR MThe New York Stock Exchange
Alerian MLP Index ETNs due May 24, 2024AMJNYSE Arca, Inc.
Guarantee of Callable Step-Up Fixed Rate Notes due June 10, 2032 of JPMorgan Chase Financial Company LLCJPM/32The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 5.02 (d)
JPMorgan Chase & Co. elected Alex Gorsky as a director, effective July 19, 2022. Mr. Gorsky is Executive Chairman of Johnson & Johnson. Mr. Gorsky's appointment to a board committee will be disclosed when determined. He was also elected a director of JPMorgan Chase Bank, N.A. and a manager of JPMorgan Chase Holdings LLC, and may be elected a director of such other subsidiary or subsidiaries as may be determined from time to time.
A copy of the firm's press release is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits

(d)    Exhibit
Exhibit No.Description of Exhibit
99.1
101Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language).
104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
JPMorgan Chase & Co.
(Registrant)


By:/s/ John H. Tribolati
John H. Tribolati
Corporate Secretary



Dated:July 19, 2022


3
JPMorgan Chase & Co. 383 Madison Avenue, New York, NY 10017-2070 NYSE symbol: JPM www.jpmorganchase.com News release: IMMEDIATE RELEASE Investor Contact: Mikael Grubb, 212-270-1717 Media Contact: Joseph Evangelisti, 212-270-7438 JPMorgan Chase Elects Alex Gorsky to its Board of Directors New York, July 19, 2022 – JPMorgan Chase (NYSE: JPM) announced today that Alex Gorsky, 62, has been elected director of the company, effective immediately. Mr. Gorsky serves as Executive Chairman of Johnson & Johnson. He previously served as Chairman and Chief Executive Officer of the company from 2012-2021. Under his leadership, Johnson & Johnson has become one of the world’s largest healthcare companies and one of the foremost innovators in research and development for emerging health technologies. His influence has shaped both the healthcare landscape and the greater business community through his work as a member of the Business Roundtable and on the Business Council. He currently sits on the boards of Apple, Inc., IBM, New York-Presbyterian Hospital, and the Travis Manion Foundation, and serves on the Wharton School of the University of Pennsylvania Board of Advisors. “Alex Gorsky is one of the most successful and respected leaders in business today, and I have known and admired him for many years, including during our work together on the Business Roundtable. His deep experience in bringing cutting-edge technology to the world’s most urgent and complex healthcare challenges and his long track record of leading innovative and diverse teams around the world will add great value to our company,” said Jamie Dimon, Chairman and CEO of JPMorgan Chase. Mr. Gorsky said, “I am excited to join the board of JPMorgan Chase, one of the most successful and influential companies in the world today. I look forward to bringing my experience to help the company navigate a rapidly evolving environment as it continues to find innovative ways to better serve customers, businesses and communities around the world.” About JPMorgan Chase JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorgan Chase had $3.8 trillion in assets and $286.1 billion in stockholders’ equity as of June 30, 2022. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world’s most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com. ###